Cancer BiologybioRxiv
Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC
N. Wamsley, E. Wilkerson, L. Guan…·M. B. Major
This paper develops a targeted proteomics assay to quantify NRF2 pathway components and clinical biomarkers in HNSCC, identifying correlations between NRF2 activity, HPV infection, and immune markers.
DOI 10.1016/j.mcpro.2023.100647